Review: the Multiple Roles of Monocytic Microparticles

Inflammation

Volumn 39, Issue 4, 2016, Pages 1277-1284

  Halim, Ahmad Tarmizi Abdul ^a   Ariffin, Nur Azrah Fazera Mohd ^a   Azlan, Maryam ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

blood coagulation; inflammation; monocyte subsets; monocytes; monocytic microparticles; phosphatidylserine

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; P SELECTIN GLYCOPROTEIN LIGAND 1; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AUTOIMMUNE DISEASE; BLOOD CLOTTING; BRAIN MALARIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFLAMMATION; LUNG CANCER; MALARIA; MEMBRANE MICROPARTICLE; METABOLIC DISORDER; MONOCYTE; MONOCYTIC MICROPARTICLE; NONHUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; REVIEW; SEPSIS; SICKLE CELL ANEMIA; ANIMAL; ENDOTHELIUM CELL; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; BLOOD COAGULATION; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MONOCYTES;

EID: 84969784942     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-016-0381-8     Document Type: Review

References (47)

1. Wu, Z.H., et al. 2013. Membrane microparticles and diseases. European Review for Medical and Pharmacological Sciences 17(18): 2420–2427.
2. Diehl, P., et al. 2012. Microparticles: Major transport vehicles for distinct microRNAs in circulation. Cardiovascular Research 93(4): 633–644.
3. Bernimoulin, M., et al. 2009. Differential stimulation of monocytic cells results in distinct populations of microparticles. Journal of Thrombosis and Haemostasis 7(6): 1019–1028.
4. Crompot, E., et al. 2015. Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: The importance of an appropriate negative control. PLoS One 10(5), e0127209.
5. Wen, B., et al. 2014. Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses. PLoS One 9(3), e91597.
6. Kanazawa, S., et al. 2003. Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer 39(2): 145–149.
7. Batool, S., N. Abbasian, J.O. Burton, and C. Stover. 2013. Microparticles and their roles in inflammation: A review. The Open Immunology Journal 6: 14.
8. Owens III, A.P., and N. Mackman. 2011. Microparticles in hemostasis and thrombosis. Circulation Research 108(10): 1284–1297.
9. Martinez, M.C., and R. Andriantsitohaina. 2011. Microparticles in angiogenesis: Therapeutic potential. Circulation Research 109(1): 110–119.
10. Kornek, M., et al. 2012. Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 143(2): 448–458.
11. Ziegler-Heitbrock, L., et al. 2010. Nomenclature of monocytes and dendritic cells in blood. Blood 116(16): e74–e80.
12. Angelillo-Scherrer, A. 2012. Leukocyte-derived microparticles in vascular homeostasis. Circulation Research 110(2): 356–369.
13. Cerri, C., et al. 2006. Monocyte/macrophage-derived microparticles upregulate inflammatory mediator synthesis by human airway epithelial cells. Journal of Immunology 177(3): 1975–1980.
14. Del Conde, I., et al. 2005. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106(5): 1604–1611.
15. Liu, M.L., et al. 2007. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arteriosclerosis, Thrombosis, and Vascular Biology 27(2): 430–435.
16. Neri, T., et al. 2011. Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. European Respiratory Journal 37(6): 1494–1502.
17. Wang, J.G., et al. 2011. Monocytic microparticles activate endothelial cells in an IL-1beta-dependent manner. Blood 118(8): 2366–2374.
18. Bardelli, C., et al. 2012. Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARgamma ligands. British Journal of Pharmacology 165(3): 716–728.
19. Mastronardi, M.L., et al. 2011. Microparticles from apoptotic monocytes enhance nitrosative stress in human endothelial cells. Fundamental and Clinical Pharmacology 25(6): 653–660.
20. Sarkar, A., et al. 2009. Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. PLoS One 4(9), e7140.
21. Eyre, J., et al. 2011. Monocyte- and endothelial-derived microparticles induce an inflammatory phenotype in human podocytes. Nephron Experimental Nephrology 119(3): e58–e66.
22. Novo, E., and M. Parola. 2008. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis & Tissue Repair 1(1): 5.
23. Dignat-George, F., and C.M. Boulanger. 2011. The many faces of endothelial microparticles. Arteriosclerosis, Thrombosis, and Vascular Biology 31(1): 27–33.
24. Aleman, M.M., et al. 2011. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. Journal of Thrombosis and Haemostasis 9(11): 2251–2261.
25. Robinson, R.A., L. Worfolk, and P.B. Tracy. 1992. Endotoxin enhances the expression of monocyte prothrombinase activity. Blood 79(2): 406–416.
26. Satta, N., J.M. Freyssinet, and F. Toti. 1997. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. British Journal of Haematology 96(3): 534–542.
27. Falati, S., et al. 2003. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. Journal of Experimental Medicine 197(11): 1585–1598.
28. Li, M., et al. 2010. Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 30(9): 1818–1824.
29. Williams, J.C., et al. 2015. Delta(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles. Journal of Inflammation (London) 12: 39.
30. Khan, M.M., et al. 2010. Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF-alpha and IL-1beta. American Journal of Physiology - Heart and Circulatory Physiology 298(2): H652–H658.
31. Bajaj, M.S., M. Ghosh, and S.P. Bajaj. 2007. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: Physiologic and pathologic implications. Journal of Thrombosis and Haemostasis 5(7): 1493–1499.
32. Hoyer, F.F., et al. 2012. Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice. Journal of Cellular and Molecular Medicine 16(11): 2777–2788.
33. Nomura, S., S. Kanazawa, and S. Fukuhara. 2002. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. Journal of Human Hypertension 16(8): 539–547.
34. Hjuler Nielsen, M., et al. 2015. Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia. PLoS One 10(4), e0121516.
35. Omoto, S., et al. 2002. Detection of monocyte-derived microparticles in patients with type II diabetes mellitus. Diabetologia 45(4): 550–555.
36. Ogata, N., et al. 2006. Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Research and Clinical Practice 73(3): 241–248.
37. Pankoui Mfonkeu, J.B., et al. 2010. Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One 5(10), e13415.
38. Idro, R., et al. 2010. Cerebral malaria: Mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatric Research 68(4): 267–274.
39. John, C.C., et al. 2008. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. American Journal of Tropical Medicine and Hygiene 78(2): 198–205.
40. Mack, M., et al. 2000. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection. Nature Medicine 6(7): 769−775.
41. Distler, J.H., et al. 2005. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proceedings of the National Academy of Sciences of the United States of America 102(8): 2892–2897.
42. Takeshita, J., et al. 2014. Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors. Journal of the American Heart Association 3(1), e000507.
43. Patel, R.V., et al. 2011. Psoriasis and vascular disease-risk factors and outcomes: A systematic review of the literature. Journal of General Internal Medicine 26(9): 1036–1049.
44. Baka, Z., et al. 2010. Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis. Immunology Letters 128(2): 124–130.
45. Nagahama, M., et al. 2003. Significance of anti-oxidized LDL antibody and monocyte-derived microparticles in anti-phospholipid antibody syndrome. Autoimmunity 36(3): 125–131.
46. Crookston, K.P., et al. 2013. Circulating microparticles in neuropsychiatric systemic lupus erythematosus. International Journal of Rheumatic Diseases 16(1): 72–80.
47. George, F.D. 2008. Microparticles in vascular diseases. Thrombosis Research 122(Suppl 1): S55–S59.